Genagon Therapeutics AB is a Swedish AB, operating in the Other research and experimental development on natural sciences and engineering sector. Incorporated in 2015, the company has 0 employees and reported revenue of SEK 214.0k in its latest annual filing.
In its most recent annual report (2023), Genagon Therapeutics AB reported revenue of SEK 214.0k, an increase of 189% on the year before. The figures on this page draw on 5 annual filings covering 2019 to 2023. The bottom line showed a net loss of SEK 164.0k, and the EBITDA margin stood at -74.3%.
At the end of 2023, equity financed 70.3% of the balance sheet, and current assets covered short-term debt 3.4 times.
Frequently asked questions
What is the Org number of Genagon Therapeutics AB?
Genagon Therapeutics AB is registered with Bolagsverket / SCB under Org 5590164082.
What is the revenue of Genagon Therapeutics AB?
Genagon Therapeutics AB reported revenue of SEK 214.0k in 2023.
